Evidence map›Paper›PMID 30306265›Full record

ArticleParasitology research2018

Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3.

Nutnicha Suphakhonchuwong, Wanna Chaijaroenkul, Kanchana Rungsihirunrat, Kesara Na-Bangchang, Jiraporn Kuesap

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Genetic diversity ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  2. Genetic diversity of theParasite epidemiology and control · 2024
    Article
  3. Genetic Diversity ofTropical medicine and infectious disease · 2023
    Article
  4. Distinct Allelic Diversity ofJournal of tropical medicine · 2023
    Article
  5. PvMSP-3α and PvMSP-3β genotyping reveals higher genetic diversity in Plasmodium vivax parasites from migrant workers than residents at the China-Myanmar border.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nutnicha SuphakhonchuwongFaculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
Wanna ChaijaroenkulChulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.
Kanchana RungsihirunratCollege of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand.
Kesara Na-BangchangChulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.
Jiraporn KuesapFaculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand. jirajira28@yahoo.com.ORCID http://orcid.org/0000-0002-3939-302X

Funding

the national research council of Thailand and Thammasat University Contract No. 040/2557 None
6 · The paper itself

Abstract

Malaria is a significant public health problem in several tropical countries including Thailand. The prevalence of Plasmodium vivax infection has been increasing in the past decades. Plasmodium vivax merozoite surface protein (PvMSP) gene encodes a malaria vaccine candidate antigen. Its polymorphic nature leads to antigenic variation, the barrier for vaccine development, drug resistance, and potential for multiple-clone infections within the malaria patients. The objective of this study was to investigate the genetic diversity of PvMSP1 and PvMSP3 gene in P. vivax populations in Thailand. A total of 100 P. vivax isolates collected from the western (Kanchanaburi and Tak Provinces) and southern (Ranong Provinces) regions along the Thai-Myanmar border were analyzed using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Analysis of the F1, F2, and F3 regions of PvMSP1 revealed 5, 2, and 3 allelic variants, respectively. Three major types of PvMSP3-α and two major types of PvMSP3-β were identified based on the PCR product sizes. After digestion with restriction enzymes, 29, 25, 26, and 18 patterns were distinguished by RFLP for PvMSP1 (F2, Alu I), PvMSP1 (F2, Mnl I), PvMSP3-α, and PvMSP3-β, respectively. Combination of each family variant (PvMSP1 and PvMSP3) resulted in high genetic polymorphism of P. vivax population. Additionally, using PvMSP1 polymorphic marker revealed a significant association between multiple-genotype infections and P. vivax parasitemia. The results strongly supported that P. vivax populations in the endemic areas along the Thai-Myanmar border are highly diverse.

Indexed as

AllelesAnimalsAntigens, ProtozoanGenotypeHumansMalaria VaccinesMalaria, VivaxMerozoitesMerozoite Surface Protein 1Plasmodium vivaxPolymerase Chain ReactionPolymorphism, GeneticPolymorphism, Restriction Fragment LengthProtozoan ProteinsThailandAntigens, ProtozoanMalaria VaccinesMerozoite Surface Protein 1merozoite surface protein 3, PlasmodiumProtozoan ProteinsMerozoite surface protein 1 (MSP1)Merozoite surface protein 3 (MSP3)Plasmodium vivaxPolymorphism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.